Silverarc Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

Silverarc Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	+545,000	New	+$1.32M	0.13%	68

Other funds holding CNTB

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return

DMKJ

David M. Knott Jr $183M AUM 73.23% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Silverarc Capital Management's CNTB Position: Q2 2026 in Review

Silverarc Capital Management opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 545,000 shares worth $1.3M. The stake represents 0.13% of the portfolio and ranks #68 among its holdings.

57 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

Silverarc Capital Management held 545,000 shares of Connect Biopharma Holdings worth $1.3M as of Q2 2026.
Connect Biopharma Holdings was a new Silverarc Capital Management position in Q2 2026.
Connect Biopharma Holdings made up 0.13% of Silverarc Capital Management's portfolio in Q2 2026, its #68 holding.
57 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.